RELATED CONTENT
NEWS
- Abbott convinces US FDA GI panel Humira colitis data ‘clinically meaningful’
- GSK and Janssen wade into competitive RA market with Phase III sirukumab program
- Janssen files Simponi in US and EU for refractory ulcerative colitis
- US FDA adds 7th feather to Humira's cap with colitis OK

